These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1454800)
1. Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment. Lisziewicz J; Sun D; Klotman M; Agrawal S; Zamecnik P; Gallo R Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11209-13. PubMed ID: 1454800 [TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates. Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903 [TBL] [Abstract][Full Text] [Related]
3. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. Balotta C; Lusso P; Crowley R; Gallo RC; Franchini G J Virol; 1993 Jul; 67(7):4409-14. PubMed ID: 8510229 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element. Li G; Lisziewicz J; Sun D; Zon G; Daefler S; Wong-Staal F; Gallo RC; Klotman ME J Virol; 1993 Nov; 67(11):6882-8. PubMed ID: 8411393 [TBL] [Abstract][Full Text] [Related]
5. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome. Anazodo MI; Wainberg MA; Friesen AD; Wright JA J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes. Zelphati O; Zon G; Leserman L Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev. Lund OS; Nielsen JO; Hansen JE Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes. Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727 [TBL] [Abstract][Full Text] [Related]
9. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity. Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960 [TBL] [Abstract][Full Text] [Related]
10. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. Lisziewicz J; Sun D; Weichold FF; Thierry AR; Lusso P; Tang J; Gallo RC; Agrawal S Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7942-6. PubMed ID: 8058738 [TBL] [Abstract][Full Text] [Related]
11. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells. Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914 [TBL] [Abstract][Full Text] [Related]
12. [Inhibition of reproduction of the human immunodeficiency virus by sense and antisense oligodeoxynucleotides]. Pokrovskiĭ AG; Pliasunova OA; Blinov VM; Vlasov VV; Svinarchuk FP; Abramova TV; Gorn VV; Konevets DA Mol Biol (Mosk); 1993; 27(5):1039-43. PubMed ID: 8246927 [TBL] [Abstract][Full Text] [Related]
13. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication. Lavigne C; Yelle J; Sauvé G; Thierry AG AAPS PharmSci; 2001; 3(1):E7. PubMed ID: 11741258 [TBL] [Abstract][Full Text] [Related]
14. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells. Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137 [TBL] [Abstract][Full Text] [Related]
15. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus. Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides. Jairath S; Vargas PB; Hamlin HA; Field AK; Kilkuskie RE Antiviral Res; 1997 Feb; 33(3):201-13. PubMed ID: 9037376 [TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms. Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Svinarchuk FP; Konevetz DA; Pliasunova OA; Pokrovsky AG; Vlassov VV Biochimie; 1993; 75(1-2):49-54. PubMed ID: 8504177 [TBL] [Abstract][Full Text] [Related]
19. Antisense oligodeoxynucleotide complementary to CXCR4 mRNA block replication of HIV-1 in COS cells. Kusunoki A; Wada A; Kurosaki N; Kimura T; Takai K; Yamamoto N; Takaku H Nucleosides Nucleotides; 1999; 18(6-7):1705-8. PubMed ID: 10474251 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus-1 proliferation by liposome-encapsulated sense DNA to the 5' tat splice acceptor site. Sullivan SM; Gieseler RK; Lenzner S; Ruppert J; Gabrysiak TG; Peters JH; Cox G; Richer L; Martin WJ; Scolaro MJ Antisense Res Dev; 1992; 2(3):187-97. PubMed ID: 1490070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]